News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
359,885 Results
Type
Article (22268)
Company Profile (31)
Press Release (337586)
Multimedia
Podcasts (75)
Webinars (6)
Section
Business (118091)
Career Advice (1397)
Deals (17142)
Drug Delivery (53)
Drug Development (41772)
Employer Resources (94)
FDA (8582)
Job Trends (8306)
News (188235)
Policy (16883)
Tag
Academia (1440)
Academic (1)
Accelerated approval (4)
Adcomms (10)
Allergies (49)
Alliances (32935)
ALS (55)
Alzheimer's disease (801)
Antibody-drug conjugate (ADC) (68)
Approvals (8617)
Artificial intelligence (166)
Autoimmune disease (13)
Automation (13)
Bankruptcy (156)
Best Places to Work (6961)
BIOSECURE Act (6)
Biosimilars (50)
Biotechnology (25)
Bladder cancer (57)
Brain cancer (11)
Breast cancer (182)
Cancer (1436)
Cardiovascular disease (110)
Career advice (1187)
Career pathing (23)
CAR-T (78)
Cell therapy (268)
Cervical cancer (13)
Clinical research (34002)
Collaboration (617)
Compensation (120)
Complete response letters (8)
COVID-19 (1408)
CRISPR (26)
C-suite (119)
Cystic fibrosis (52)
Data (1490)
Decentralized trials (2)
Denatured (24)
Depression (24)
Diabetes (186)
Diagnostics (3370)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (29)
Drug discovery (73)
Drug pricing (55)
Drug shortages (18)
Duchenne muscular dystrophy (64)
Earnings (54873)
Editorial (31)
Employer branding (12)
Employer resources (82)
Events (54173)
Executive appointments (394)
FDA (9347)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (403)
Gene editing (60)
Generative AI (18)
Gene therapy (209)
GLP-1 (414)
Government (2224)
Grass and pollen (4)
Guidances (56)
Healthcare (10111)
Huntington's disease (12)
IgA nephropathy (17)
Immunology and inflammation (72)
Indications (22)
Infectious disease (1481)
Inflammatory bowel disease (89)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (62)
Interviews (260)
IPO (8274)
IRA (26)
Job creations (1696)
Job search strategy (985)
Kidney cancer (4)
Labor market (21)
Layoffs (211)
Leadership (16)
Legal (4344)
Liver cancer (34)
Lung cancer (212)
Lymphoma (97)
Machine learning (2)
Management (32)
Manufacturing (177)
MASH (48)
Medical device (6566)
Medtech (6570)
Mergers & acquisitions (9226)
Metabolic disorders (441)
Multiple sclerosis (51)
NASH (9)
Neurodegenerative disease (49)
Neuropsychiatric disorders (14)
Neuroscience (1116)
NextGen: Class of 2025 (3360)
Non-profit (2675)
Now hiring (5)
Obesity (218)
Opinion (152)
Ovarian cancer (42)
Pain (52)
Pancreatic cancer (49)
Parkinson's disease (86)
Partnered (12)
Patents (140)
Patient recruitment (60)
Peanut (23)
People (26913)
Pharmaceutical (9)
Pharmacy benefit managers (8)
Phase I (10151)
Phase II (14444)
Phase III (12138)
Pipeline (942)
Policy (85)
Postmarket research (1631)
Preclinical (4483)
Press Release (31)
Prostate cancer (92)
Psychedelics (18)
Radiopharmaceuticals (145)
Rare diseases (230)
Real estate (2521)
Recruiting (36)
Regulatory (11497)
Reports (16)
Research institute (1316)
Resumes & cover letters (214)
Rett syndrome (2)
RNA editing (3)
RSV (23)
Schizophrenia (43)
Series A (73)
Series B (39)
Service/supplier (3)
Sickle cell disease (35)
Special edition (7)
Spinal muscular atrophy (68)
Sponsored (17)
Startups (1471)
State (1)
Stomach cancer (9)
Supply chain (30)
Tariffs (20)
The Weekly (50)
Vaccines (395)
Venture capitalists (18)
Weight loss (134)
Women's health (17)
Worklife (12)
Date
Last 7 days (540)
Last 30 days (1477)
Last 365 days (19127)
2025 (6595)
2024 (20128)
2023 (22132)
2022 (27903)
2021 (29690)
2020 (29016)
2019 (24969)
2018 (18451)
2017 (17383)
2016 (16924)
2015 (19283)
2014 (16176)
2013 (14155)
2012 (13978)
2011 (13392)
2010 (12623)
Location
Africa (530)
Alabama (39)
Alaska (4)
Arizona (85)
Arkansas (7)
Asia (20905)
Australia (3431)
California (3443)
Canada (1182)
China (304)
Colorado (174)
Connecticut (183)
Delaware (90)
Europe (49363)
Florida (607)
Georgia (136)
Idaho (20)
Illinois (296)
India (19)
Indiana (201)
Iowa (3)
Japan (107)
Kansas (56)
Kentucky (9)
Louisiana (4)
Maine (27)
Maryland (497)
Massachusetts (2647)
Michigan (124)
Minnesota (175)
Missouri (34)
Montana (8)
Nebraska (9)
Nevada (45)
New Hampshire (29)
New Jersey (1162)
New Mexico (12)
New York (1045)
North Carolina (609)
North Dakota (4)
Northern California (1510)
Ohio (104)
Oklahoma (11)
Oregon (18)
Pennsylvania (823)
Puerto Rico (1)
Rhode Island (20)
South America (740)
South Carolina (15)
Southern California (1327)
Tennessee (66)
Texas (514)
United States (13493)
Utah (118)
Virginia (77)
Washington D.C. (41)
Washington State (320)
West Virginia (2)
Wisconsin (27)
359,885 Results for "welsh carson anderson and stowe".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Adaeze Enekwechi Joins Welsh, Carson, Anderson & Stowe as an Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Dr. Adaeze Enekwechi will join the firm in June as an Operating Partner.
May 25, 2021
·
4 min read
Business
Welsh, Carson, Anderson & Stowe Commits $250 Million in a Strategic Partnership with Kiniciti, a Newly-Formed Platform Investing in Cell and Gene Therapy Companies
Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that it is committing up to $250 million to a strategic partnership with Kiniciti, a newly-formed platform.
February 1, 2021
·
5 min read
Earnings
Bayer Earnings ‘Not Pretty,’ CEO Bill Anderson Admits As He Urges Calm
Bayer reported a decline of 37% in earnings per share on Tuesday, which sent its stock down 12%. CEO Bill Anderson urged investors to be patient as the company executes on a performance-boosting strategy outlined in March.
November 12, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre
February 19, 2025
·
3 min read
Business
OneOncology Partners with Anderson Area Cancer Center
Anderson Area Cancer Center and OneOncology announced a finalized partnership to enhance the delivery of cancer services in and around Anderson, South Carolina.
June 24, 2024
·
2 min read
Business
Lee Cooper Joins Welsh, Carson, Anderson & Stowe As An Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Lee Cooper, an accomplished healthcare executive, has joined the firm as an Operating Partner.
October 7, 2019
·
2 min read
Press Releases
Texas Children’s Hospital and UT MD Anderson Announce Joint Venture to End Childhood Cancer
February 19, 2025
·
4 min read
Business
Dan Mendelson Joins Welsh, Carson, Anderson & Stowe As An Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe announced today that Dan Mendelson, a highly-regarded executive in the healthcare industry, has joined the firm’s Healthcare team as an Operating Partner.
April 8, 2019
·
2 min read
Business
Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul
Since taking the helm in 2023, Anderson has embarked on a radical departure from the traditional structure of large pharma companies. Will getting rid of management layers fix Bayer?
May 17, 2024
·
3 min read
·
Greg Slabodkin
Press Releases
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
February 20, 2025
·
3 min read
1 of 35,989
Next
